SCHEMBL2658993

SCHEMBL2658993

Cc1ccc(S(=O)(=O)Oc2n[nH]c(C(C)O)c2C2CCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 2/20 0.39
ENPP1 P22413 2/20 0.39
ENPP2 Q13822 2/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
HTR6 P50406 1/20 0.37
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
DRD3 P35462 1/20 0.34
LMNA P02545 4/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2658331 0.81 ENPP3 (0.42) ENPP3ENPP1ENPP2KEAP1NFE2L2
SCHEMBL6297239 0.77 KEAP1 (0.40) KEAP1NFE2L2LMNAALDH1A1MAPT
SCHEMBL2658907 0.74 KEAP1 (0.41) KEAP1NFE2L2LMNAALDH1A1SMN1; SMN2
SCHEMBL2657702 0.66 CYP2C19 (0.40) KEAP1NFE2L2LMNAALDH1A1MAPT
SCHEMBL23461873 0.66 CYP2C19 (0.37) ENPP3ENPP1ENPP2KEAP1NFE2L2
SCHEMBL29975532 0.66 CYP2C19 (0.37) ENPP3ENPP1ENPP2KEAP1NFE2L2
SCHEMBL11027524 0.66 GAA (0.46) KEAP1NFE2L2LMNAALDH1A1SMN1; SMN2
SCHEMBL4578793 0.65 ALDH1A1 (0.49) ENPP3ENPP1ENPP2LMNAALDH1A1
SCHEMBL10181538 0.65 ENPP3 (0.59) ENPP3ENPP1ENPP2DRD2DRD1
SCHEMBL16111000 0.65 KEAP1 (0.51) KEAP1NFE2L2LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872720-B2 Pyrazolo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. 2005-03-29 US disclosed
US-20030060467-A1 Pyrazolo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. (GB) 2003-03-27 US disclosed
EP-1282623-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LTD. (GB) 2003-02-12 EP disclosed
WO-2001077111-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060467-A1 Pyrazolo-triazine derivatives as ligands for gaba receptors GABRA5, GABRA3, GABRA4 ENPP3 3804/4885ENPP1 4539/4885ENPP2 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.